NCT03815643 2026-03-31Avelumab Program Rollover StudyEMD SeronoPhase 3 Active not recruiting205 enrolled
NCT04260802 2026-01-12A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersOcellaris Pharma, Inc.Phase 1/2 Terminated73 enrolled
NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT01772004 2021-12-20Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)EMD SeronoPhase 1 Completed1,756 enrolled 59 charts
NCT02222922 2020-12-17A Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsPfizerPhase 1 Completed138 enrolled 98 charts